Mexican pharmacies and antibiotic consumption at the US-Mexico border

Southern Med Review

Volumn 5, Issue 2, 2012, Pages 9-19

  Homedes, Núria ^a   Ugalde, Antonio ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Antibiotics; Mexico; Pharmacists; Pharmacy clerks; US Mexico border

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DRUG INDUSTRY; DRUG USE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MALE; MEDICAL EDUCATION; MEDICAL PRACTICE ACT; MEXICO; PHARMACIST; PHARMACY; PHARMACY CLERK; PRESCRIPTION; PURCHASING; QUESTIONNAIRE; SELF MEDICATION; THROAT DISEASE; TREATMENT INDICATION; UNITED STATES;

EID: 84874271954     PISSN: 11742704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Nicogossian A et al. Anti-microbial drug resistance: A human disaster in the making. World Medical & Health Policy 2011; 3(2): Article 1. DOI:10.2202/1948-4682.1172. http://www.psocommons.org/wmhp/vol3/iss2/art1/ (Accessed 24 September 2011)
2. Neuman W, Sayari S. Egyptian seeds linked to European E. Coli outbreaks. The New York Times, June 29, 2011. http://www.nytimes.com/2011/06/30/world/middleeast/30ecoli.html (Accessed 24 September 2011)
3. Kristof ND. The spread of superbugs. The New York Times, March 7, 2010. http://www.nytimes.com/2010/03/07/opinion/07kristof.html (Accessed 24 September 2011
4. Institute of Medicine. Antibiotic Resistance: Implications for global health and novel intervention strategies: workshop summary. Washington DC: The National Academy Press 2010.
5. Wernli D et al. A call to action: the application of the International Health Regulations to the global threat of antimicrobial resistance. PLoS Medicine 2011; 8 (4): e1001022
6. Monssialos E et al. Policies and incentives fro promoting innovation in antibiotic research. Geneva; WHO on behalf of the European Observatory of Health Systems and Policies, 2010.
7. European Center for Disease Prevention and Control, and European Medicines Agency. The bacterial challenge: time to react. Stockholm: EMEA, EMEA/576176/2009. 2009.
8. Paddock C. The antibiotics crisis: how did we get here and where do we go next? Medical News Today, January 10, 2011. http://www.medicalnewstoday.com/articles/213193.php (Accessed 24 September 2011)
9. Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiple-resistant bacterial pathogens. JAMA 1996; 275: 300-3004.
10. Bronzwaer SL et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infecti Dis 2002; 8:278-82.
11. Amábile-Cuevas CF. Antibiotic resistance in Mexico: a brief overview of the current status and its causes. J Infect Dev Ctries 2010; 4(3): 126-131.
12. Combs S. Visiting la Farmacia. In Texas Comptroller. State Government. Bordering the Future. July 1998. http://www.window.state.tx.us/border/border.html (Accessed 24 September 2011)
13. Taylor JP et al. Epidemiology of Drug-resistant tuberculosis in Texas. American Journal of Epidemiology 1999; 149 (4): 359-365.
14. Centers for Disease Control and Prevention (CDC). Population-based survey for drug resistance tuberculosis-Mexico, 1997. MMWR 1998; 47:371-375.
15. Escobedo M, Cosio FG. Tuberculosis and the United States-Mexico border. J Border Health 1997; 2:40-47.
16. Taylor JP, Suarez L. Prevalence and risk factors of drug-resistant tuberculosis along the Mexico-Texas Border. AJPH 2000; 90(2):271-273.
17. Vasquez Y, Hand WL. Antibiotic susceptibility patterns of community-acquired urinary tract infection isolates from female patients on the US (Texas)-Mexico Border. The Journal of Applied Research 2004; 4(2): 321-326. http://www.jarcet.com/articles/Vol4Iss2/Vasquez-Jar-spring.pdf (Accessed 24 September 2011)
18. Ammons DR et al. An exploratory study of methicillin-resistant Staphylococcus aureus and SCCmec elements obtained from a community setting along the Texas Border with Mexico. Curr Mibrobiol 2010; 60(5): 321-326. DOI 10.1007/s00284-009-9544-2. http://www.springerlink.com/content/r3x62j8056207h7v/ (Accessed 24 September 2011)
19. Rivera JO et al. Study of methicillin-resistant Staphylococcus aureus on the US-Mexico Border. Travel Medicine and Infectious Disease 2009; 7:30-34.
20. Broussard CS et al. Exposure to antibiotics in a United States-Mexico Border birth cohort. Pediatrics 1010; 125:e1468.
21. Pylpa J. Self-medication practices in two California-Mexican communities. J Immigr Health 2001; 3(2): 59-75.
22. De Guzman GC et al. A survey of the use of foreign-purchased medications in a border community emergency department patient population. J Emerg Med 2007; 33(2): 213-221.
23. Lunday S. When purchasing medicine in Mexico, buyer beware. The New York Times, April 17, 2001. http://www.nytimes.com/2001/04/17/health/when-purchasing-medicine-in-mexico-buyer-beware.html (Accessed September 24, 2011)
24. Calvillo JP, Lal L. Pilot study of a survey of US residents purchasing medications in Mexico: demographics, reasons and types of medications purchased. Clin Ther 2003; 25(2): 561-577.
25. Wirtz V et al. [Organization and operation of the Mexican pharmacies]. In Homedes N Ugalde A eds. [Pharmacies, pharmacists and the appropriate use of pharmaceuticals in Latin America] Buenos Aires: Editorial Lugar 2011.pp 59-82 [In Spanish].
26. Dreser A et al. [Mexican pharmacies: regulation and policies]. In Homedes N Ugalde A eds. [Pharmacies, pharmacists and the appropriate use of pharmaceuticals in Latin America] Buenos Aires: Editorial Lugar 2011, pp 27-57. [In Spanish]
27. Manious AG et al. Factors affecting Latin adults' use of antibiotics for self-medication. JABFM 2008; 21(2): 128-134.
28. Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med 2007; 20:533-539.
29. Families USA Foundation. Crossing to Mexico. Priced out of American Health Care. Washington DC. Families USA Foundation 1992.
30. Casner PR, Guerra LG. Purchasing prescription medication in Mexico without a prescription. The experience at the border. West J Med 1992; 156: 512-16.
31. Texas Department of State Health Services. Office of Border Health. 2007 Health Risk Factors in the Texas-Mexico Border. Austin: Texas Department of State Health Services, no date.
32. Escobedo L, Cardenas VM. Utilization and purchase of medical care services in Mexico by residents in the United States of America 1998-1999. Rev Panam Salud Pública 2006; 19(5): 300-305.
33. Rivera JO et al. Cross-border purchase of medications and health care in a sample of residents of El Paso, Texas, and Ciudad Juarez, Mexico. J Natl Med Assoc 2009; 101(2):167-173.
34. Coffman MJ et al. Self-prescription practices in recent Latino Immigrants. Public Health Nurs 2008; 25(3): 203-211.
35. Homedes N. The Health Seeking Behavior of Undocumented Immigrants in El Paso County. Report for the Center for Border Health Research, 145 pages. 2008.
36. US Department of Health, Education and Welfare. A reason for visit classification for ambulatory care. Hyattsville, MD: DHEW Publication number (PHS) 79-1352, 1979.
37. Quiroz T. [Mexico: how some pharmacies operate]. Boletín Fármacos 2011; 14 (1). http://www.saludyfarmacos.org/boletin-farmacos/boletines/feb2011/Mexico-funcionamiento-de-algunas-farmacias/ (Accessed September 24, 2011)
38. Escutia Gutiérrez MFR. Situación actual de los Servicios Farmacéuticos en México. Instituto Palia- Secretaría de Salud Jalisco, Ex delegado de O.F.I.L., México http://www.foroibercisalud.com/docs/articulos/Situacion_FarmaceuticosMexico.pdf
39. Volpato DE et al. Use of antibiotics without medical prescription. Braz J Infect Dis.2005;9(4):288-91.
40. World Health Organization. World Health Statistics. Geneva: WHO 2011. p 120. http://www.who.int/whosis/whostat/EN_WHS2011_Full.pdf (Accessed September 24, 2011)
41. Wirtz VJ et al. Trends in antibiotic utilization in eight Latin American countries 1997-2007. Rev Panam Salud Pública 2010; 27(3): 219-225.
42. Arnold SR, Strauss SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews 2005; 4: CD003539.
43. Bennett D et al. Competing doctors, antibiotic use, and antibiotic resistance in Taiwan. January 7, 2009. http://chess.uchicago.edu.ezproxyhost.library.tmc.edu/events/hew/fall08/bennett.pdf (Accessed September 24, 2011)
44. Resi D, Milnadrui M, More ML and the Emilia Romagna Study Group on the use of antibiotic in children. Antibiotic prescriptions in children. J Antimicrob Chemother 2003; 52: 282-286.DOI: 10.1093/jac/dkg302. http://jac.oxfordjournals.org/content/52/2/282.full.pdf+html (Accessed September 24, 2011)
45. Masiero MG, Ferech M, Goossens H. Determinants of outpatient antibiotic consumption in Europe: bacterial resistance and drug prescribers. Quaderno N 07-02. 2007. http://ideas.repec.org/p/lug/wpaper/0702.html (Accessed September 24, 2011)
46. Steinman MA et al. Variation in outpatient antibiotic prescribing in the United States. Am J Manag Care 2009; 15 (12): 861-868.
47. Manious AG, Hueston WJ. Controlling antibiotic resistance: will we someday see limited prescribing autonomy? Am Fam Physician 2001; 63(6):1034-1039.
48. Ranji SR et al. Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis. Med Care 2008; 46 (8):847-862.
49. Mroz RC Jr, Pillai SD. Bacterial population in the groundwater on the US-Mexico border in El Paso County. Texas South Med Journal 1994; 87:214-7.
50. Pillai SD et al. Antibiotic resistance profiles of Escherichia coli isolated from rural and urban environments. J Environ Sci Health 1997; 32:1665-75.
51. International Boundary and Water Commission. Water Bulletin #63: Flow of the Rio Grande and related data. El Paso (Texas):The Commission, 1993, p 132.
52. Scandura JE, Sobsey MD. Viral and bacterial contamination of groundwater from on-site sewage treatment systems. Water Sci Technol 1997; 35:141-46.
53. Roe MT et al. Antimicrobial resistance markers of class 1 and class 2 integron-bearing Escherichia coli from irrigation water and sediments. Emerg Infect Diseases 2003; 9(7): 822-826.
54. Ryu H et al. An assessment of water quality and microbial risk in Rio Grande basis in the United States-Mexican border region. Journal of Water and Health 2005; 3(2): 209-218.